Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

News > All

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 4364 | Ordered by Date (descending)
1 2 3 ... 42 43 44  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Inflazome Ltd.. (9/21/20). "Press Release: Inflazome Announces Acquisition by Roche". Dublin & Cambridge. 2020-09-21
Immune Regulation Ltd.. (9/21/20). "Press Release: Immune Regulation Limited Raises £40.6 Million / $53.4 Million Series B Equity Financing". London & Boston, MA. 2020-09-21
Compass Pathways plc. (9/18/20). "Press Release: Compass Pathways Announces Pricing of Upsized Initial Public Offering". London. 2020-09-18
Dinaqor AG. (9/16/20). "Press Release: Dinaqor AG Appoints Eduard Ayuso as Chief Technology Officer". Pfäffikon. 2020-09-16
Proteome Sciences plc. (9/14/20). "Press Release: Appointment of Chief Executive Officer". 2020-09-14
Neogene Therapeutics, Inc.. (9/14/20). "Press Release: Neogene Therapeutics Raises $110 Million Series A Financing to Develop Next-Generation Fully Personalized Neo-Antigen T Cell Receptor (TCR) Therapies". New York, NY & Amsterdam. 2020-09-14
ERS Genomics Ltd.. (9/14/20). "Press Release: ERS Genomics Provides Comment on US Patent Office Motions Decisions in CRISPR/Cas9 Interference Case". Dublin. 2020-09-14
MiNA Therapeutics Ltd.. (9/10/20). "Press Release: MiNA Therapeutics Secures £23 Million Series A Financing to Advance First-in-Class Activating RNA-Based Therapeutics". London. 2020-09-10
Bayer Pharmaceuticals Corporation. (9/9/20). "Press Release: Bayer Completes Acquisition of the UK-based Biotech Company Kandy Therapeutics Ltd.". Whippany, NJ. 2020-09-09
Evonetix Ltd.. (9/9/20). "Press Release: Evonetix and Analog Devices Collaborate onThird-Generation DNA Synthesis Platform". Cambridge. 2020-09-09
Modulus Oncology Ltd.. (9/9/20). "Press Release: University of Sheffield Spin-out Modulus Oncology to Advance New Drug Targeting Hard-to-treat Cancers". Sheffield. 2020-09-09
Metrion Biosciences Ltd.. (9/8/20). "Press Release: Metrion Biosciences Strengthens Global Business Development Team". Cambridge. 2020-09-08
CN Bio Innovations Ltd.. (9/8/20). "Press Release: CN Bio and Imperial College London Collaborate to Identify Novel Treatments for Alcoholic Hepatitis ". Cambridge & London. 2020-09-08
PhoreMost Ltd.. (9/8/20). "Press Release: PhoreMost and XtalPi Sign AI-based Pharmaceutical drug Discovery Collaboration Agreement". Cambridge & Cambridge, MA. 2020-09-08
Umotif Ltd.. (9/3/20). "Press Release: Umotif Raises £5 Million to Power Decentralised Clinical Trials and Get Therapies to Patients Faster". London. 2020-09-03
EuropaBio. (9/3/20). "Press Release: Novartis’s Andrew Topen Appointed as New Chairman of EuropaBio". 2020-09-03
Evotec SE. (9/2/20). "Press Release: Evotec Expands Its Proprietary Patient Database into Liver Disease with Unique Access to QUOD Biobank". Hamburg. 2020-09-02
Oxford BioMedica plc. (9/1/20). "Press Release: Oxford Biomedica Signs Supply Agreement with AstraZeneca to Expand Manufacturing Support of COVID-19 Vaccine Candidate, AZD1222". Oxford. 2020-09-01
Biocartis Group N.V.. (9/1/20). "Press Release: Biocartis Expands Collaboration with LifeArc". Mechelen & London. 2020-09-01
Axol Bioscience Ltd.. (8/27/20). "Press Release: Axol Bioscience Appoints Liam Taylor as Chief Executive Officer". Cambridge. 2020-08-27
Cellink AB. (8/27/20). "Press Release: Cytena and AstraZeneca Collaborate to Develop Plate Based Microbioreactors for Cell Line Development Workflows". 2020-08-27
Autifony Therapeutics Ltd.. (8/26/20). "Press Release: Autifony Therapeutics Regains Rights to Clinical Stage Kv3 Programme". Stevenage. 2020-08-26
Engitix Ltd.. (8/25/20). "Press Release: Engitix Signs Collaboration and Licensing Agreement with Takeda to Develop Anti-Fibrotic Therapies in Advanced Liver Diseases". London. 2020-08-25
Mobilion Systems, Inc.. (8/17/20). "Press Release: Mobilion Closes $35M Series B Financing Round". Chadds Ford, PA. 2020-08-17
Novo Holdings A/S. (8/12/20). "Press Release: Novo Ventures Portfolio Company F2G Closes US$60.8 Million Financing". Copenhagen. 2020-08-12
Bayer AG. (8/11/20). "Press Release: Bayer to Acquire UK-based Biotech Kandy Therapeutics Ltd. [Not intended for U.S. and UK Media]". Berlin. 2020-08-11
Oasmia Pharmaceutical AB. (8/10/20). "Press Release: Oasmia Pharmaceutical Appoints Peter Selin as Chief Business Officer". Uppsala. 2020-08-10
Histologix Ltd.. (8/5/20). "Press Release: Histologix Appoints New Managing Director to Take Company through Ambitious Growth Plans". 2020-08-05
Affimed N.V.. (8/5/20). "Press Release: Affimed Announces Two New Appointments to Its Supervisory Board". Heidelberg. 2020-08-05
GentiBio, Inc.. (8/5/20). "Press Release: GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimmune and Infl 2020-08-05
Redx Pharma plc. (8/4/20). "Press Release: Redx Signs Out Licensing Agreement with AstraZeneca". Alderley Park. 2020-08-04
UCL Business. (8/3/20). "Press Release: UCL Technology Fund Announces First Close of £100m Fund 2". 2020-08-03
Valo Therapeutics Ltd.. (8/3/20). "Press Release: Valo Therapeutics Appoints Industry Veteran Paul G Higham as CEO". Oxford & Helsinki. 2020-08-03
GlaxoSmithKline plc. (7/31/20). "Press Release: Sanofi and GSK in Advanced Discussions with European Union to Supply up to 300 Million Doses of COVID-19 Vaccine". London & Paris. 2020-07-31
GlaxoSmithKline plc. (7/31/20). "Press Release: Sanofi and GSK Selected for Operation Warp Speed to Supply United States Government with 100 Million Doses of COVID-19 vaccine". London & Paris. 2020-07-31
Genespire S.r.l.. (7/30/20). "Press Release: Genespire Appoints Jörn Aldag as Chairman of the Board of Directors". Milan. 2020-07-30
Coulter Partners. (7/28/20). "Press Release: Coulter Partners Secures Chief Executive Officer for Optimapharm". 2020-07-28
Enthera S.r.l.. (7/28/20). "Press Release: Enthera Pharmaceuticals Raises €28 Million in Series A Financing to Advance Restorative Therapy for Type 1 Diabetes and Inflammatory Bowel Disease". Milan. 2020-07-28
Abzena Ltd.. (7/28/20). "Press Release: Abzena Receives Growth Capital Investment from Newly Launched Biospring Partners". Cambridge, Bristol, PA & San Diego, CA. 2020-07-28
ExeVir Bio B.V.. (7/28/20). "Press Release: ExeVir Bio to Accelerate Development of New Treatment Conferring Broad Protection Against COVID-19. EUR23M Series A Financing to Advance Lead Novel Llama-derived Antibody into Clinical Trials". Leuven. 2020-07-28
CureVac AG. (7/21/20). "Press Release: CureVac Raises a Total of USD 640 Million in Private Financing Round". Tübingen. 2020-07-21
Apollo Therapeutics Fund. (7/21/20). "Press Release: UCLB and Apollo Therapeutics Secure First Out-licensing Deal to Deerfield, a Leading U.S. Healthcare Investment Firm". London & New York, NY. 2020-07-21
Optimapharm d.d.. (7/21/20). "Press Release: Optimapharm Appoints Dr. Andrew Copestake as Chief Executive Officer". 2020-07-21
Valneva S.E.. (7/20/20). "Press Release: Valneva Confirms Participation in UK Government COVID-19 Vaccine Response Program". Saint-Herblain. 2020-07-20
CureVac AG. (7/20/20). "Press Release: GSK and CureVac Announce Strategic mRNA Technology Collaboration". 2020-07-20
BioNTech SE. (7/20/20). "Press Release: Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2". New York, NY & Mainz. 2020-07-20
[iito] Business Intelligence. (7/15/20). "Press Release: [iito] Launches ADucation Campaign Summer 2020". Bremen. 2020-07-15
Inflazome Ltd.. (7/14/20). "Press Release: FDA Grants Orphan Drug Designation for Inflazome’s Inzomelid for the Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)". Dublin, Cambridge & Brisbane. 2020-07-14
Macomics Ltd.. (7/14/20). "Press Release: Macomics, an Immuno-oncology Company, Secures £3.2 Million Seed Funding from Epidarex Capital & the Scottish Investment Bank". Edinburgh. 2020-07-14
iOnctura S.A.. (7/14/20). "Press Release: iOnctura Extends Series A to EUR 20.1m". Geneva. 2020-07-14
Kiadis Pharma N.V.. (7/13/20). "Press Release: Kiadis Appoints Ray Barlow, Ph.D. as Chief Business Officer and Govert Schouten, Ph.D. as Head of Innovation to Kiadis Management Team". Amsterdam. 2020-07-13
Novo Holdings A/S. (7/9/20). "Press Release: Major Danish Contribution to Billion-dollar Global Initiative to Combat Antimicrobial resistance". Copenhagen. 2020-07-09
Forbion Capital Partners. (7/9/20). "Press Release: Forbion Announces First Close of Forbion Growth Opportunities Fund at EUR 185 million (USD 208 million)". Naarden & Munich. 2020-07-09
VelosBio Inc.. (7/8/20). "Press Release: VelosBio Raises $137 Million in Series B Financing to Advance Development of ROR1-Directed Therapeutics in Oncology". 2020-07-08
Mission Therapeutics Ltd.. (7/6/20). "Press Release: Mission Raises $15m and Expands its Relationship with Pfizer". Cambridge. 2020-07-06
Paion AG. (7/2/20). "Press Release: Paion Announces U.S. FDA Approval of Remimazolam (Byfavo) for the Induction and Maintenance of Procedural Sedation". Aachen. 2020-07-02
BRAIN AG. (7/2/20). "Press Release: BRAIN AG Purchases the Outstanding 24.7% Minority Stake of WeissBioTech GmbH". Zwingenberg. 2020-07-02
Metronomia Clinical Research GmbH. (7/1/20). "Press Release: Denise Lee Joins Metronomia as Managing Director". 2020-07-01
Roslin Cell Therapies Ltd. (RoslinCT). (6/25/20). "Press Release: RoslinCT Announces the Construction of a New Cell and Gene Therapy Manufacturing Facility". Edinburgh. 2020-06-25
BioGeneration Ventures B.V.. (6/24/20). "Press Release: BioGeneration Ventures Closes BGV IV Fund at €105 Million". Naarden. 2020-06-24
Scenic Biotech B.V.. (6/23/20). "Press Release: Scenic Biotech Awarded €3.1 Million Innovation Credit from Dutch Government to Progress CD47/QPCTL Immuno-oncology Program". Amsterdam. 2020-06-23
Epidarex Capital. (6/22/20). "Press Release: Epidarex Capital Closes New £102 Million UK Venture Fund to Build Successful Life Science Companies". Edinburgh. 2020-06-22
Valneva S.E.. (6/18/20). "Press Release: Valneva and Bavarian Nordic Announce Marketing and Distribution Partnership". Saint-Herblain. 2020-06-18
Biognosys AG. (6/17/20). "Press Release: Biognosys Announces Appointment of Dr. Patrick Vink as Chairman". Schlieren. 2020-06-17
GlaxoSmithKline plc. (6/16/20). "Press Release: Ideaya and GSK Announce a Broad Partnership in Synthetic Lethality, an Emerging Field in Precision Medicine Oncology". South San Francisco, CA & London. 2020-06-16
Ikarovec Ltd.. (6/15/20). "Press Release: Ikarovec Awarded Grant by Innovate UK to Develop New Wet AMD Gene Therapy". Norwich. 2020-06-15
Bit Bio Ltd.. (6/13/20). "Press Release: Bit Bio Secures $41.5m of Funding from Top Life Sciences Investors". Cambridge. 2020-06-13
Entasis Therapeutics Inc.. (6/11/20). "Press Release: Entasis Therapeutics Completes Closing of Second Tranche of $35M Private Placement with Innoviva". Waltham, MA. 2020-06-11
BioIndustry Assocation (BIA). (6/11/20). "Press Release: £30 Million Biomedical Catalyst to Launch Following Successful BIA Campaign". 2020-06-11
Applied Process Company Ltd. (APC Ltd.). (6/10/20). "Press Release: Irish Company APC Partners with Australian Biotechnology Firm Vaxine to Accelerate the Development and Delivery of New Covid-19 Vaccine candidate". Dublin. 2020-06-10
Scienion AG. (6/9/20). "Press Release: Scienion and Randox Expand Collaboration to Transform High Throughput Biochip Manufacturing". Berlin & Crumlin. 2020-06-09
Boehringer Ingelheim. (6/8/20). "Press Release: New Consortium EUbOPEN Will Provide Tools to Unlock Disease Biology. 66 Million Euros to Generate Open-access Chemical Tools". Frankfurt & Ingelheim. 2020-06-08
Oxford Biomedica plc. (6/8/20). "Press Release: Oxford Biomedica Signs Five Year Collaboration Agreement with the Vaccines Manufacturing and Innovation Centre". Oxford. 2020-06-08
Arix Bioscience plc. (6/8/20). "Press Release: Arix Announces Strategic and Operational Update. Christian Schetter Assuming Managing Director Role". London. 2020-06-08
Valo Therapeutics Ltd.. (6/8/20). "Press Release: Valo Therapeutics Announces Board Appointment of Dr Mai-Britt Zocca". Oxford & Helsinki. 2020-06-08
BRAIN AG. (6/4/20). "Press Release: BRAIN AG Successfully Placed New Capital for the Financing of further Growth". Zwingenberg. 2020-06-04
Immatics Biotechnologies GmbH. (6/4/20). "Press Release: Immatics Appoints Cedrik Britten as Chief Medical Officer". Houston, TX & Tübingen. 2020-06-04
Tropic Biosciences UK Ltd.. (6/4/20). "Press Release: Tropic Biosciences Raises $28.5 Million Series B Financing to Transform the Massive Tropical Agriculture Industry". Norwich. 2020-06-04
GHO Capital Partners LLP. (6/3/20). "Press Release: GHO Capital Acquires X-Chem, a Leading Drug Discovery Service Provider". London. 2020-06-03
Prilenia Therapeutics B.V.. (6/3/20). "Press Release: Prilenia Therapeutics Raises $62.5m to Fund Late Stage Trials in HD and ALS". Naarden & Herzliya. 2020-06-03
Novo Holdings A/S. (6/3/20). "Press Release: Novo Ventures Leads US$55m Series B Investment in NodThera". Copenhagen. 2020-06-03
Base Genomics Ltd.. (6/3/20). "Press Release: Base Genomics Announces Company Launch and Raises $11 Million USD to Commercialize Epigenetic Technology for Early and Sensitive Detection of Cancer from Liquid Biopsy". Oxford. 2020-06-03
Rigenerand S.r.l.. (6/2/20). "Press Release: Rigenerand Receives Regulatory Approval for Gene Therapy Production". Modena. 2020-06-02
Albumedix Ltd.. (6/1/20). "Press Release: Albumedix Announces Appointment of Gregor Kawaletz as Chief Commercial Officer". 2020-06-01
Exscientia Ltd.. (5/26/20). "Press Release: Exscientia Raises $60 Million in Series C Financing Round Led by Novo Holdings". Oxford, Copenhagen & Hamburg. 2020-05-26
Albumedix Ltd.. (5/26/20). "Press Release: Albumedix Announces Jonas Skjødt Møller as New Chief Executive Officer". 2020-05-26
Oxford Nanopore Technologies Ltd.. (5/26/20). "Press Release: Oxford Nanopore Announces £48.4M ($59.2M) in New Capital to Support Ongoing Innovation and the Rapid Worldwide Growth of Nanopore Sequencing". Oxford. 2020-05-26
HotSpot Therapeutics, Inc.. (5/21/20). "Press Release: HotSpot Therapeutics Completes $65 Million Series B Financing to Advance Pipeline of Novel Allosteric Medicines". Boston, MA. 2020-05-21
GlaxoSmithKline plc. (5/21/20). "Press Release: GSK Partners with Samsung Biologics to Secure Additional Manufacturing Capacity for Innovative Biopharmaceutical Portfolio". London & Songdo. 2020-05-21
Rentschler Biopharma SE. (5/19/20). "Press Release: Rentschler Biopharma Licenses Horizon Discovery's CHOSource Platform to Complement Cell Line Development Offering for Difficult-to-Express Proteins". Laupheim, Milford, MA & Cambridge. 2020-05-19
Holmusk. (5/18/20). "Press Release: Holmusk Announces Closing of US$21.5 Million Series A Funding Round, Led by Optum Ventures & Health Catalyst Capital". Singapore, London & New York, NY. 2020-05-18
Genespire S.r.l.. (5/13/20). "Press Release: Genespire and SR-Tiget Announce Strategic Alliance for the Development of Transformative Gene Therapies for Genetic Diseases and Disclose Collaboration Focus". Milan. 2020-05-13
CellGenix GmbH. (5/13/20). "Press Release: Ori Biotech and CellGenix to Collaborate in Order to Promote Innovation within Closed-system, Cell and Gene Therapy Manufacturing". Freiburg & London. 2020-05-13
TRG Management LLP. (5/12/20). "Press Release: The Rohatyn Group Completes Investment in European Contract Research Organization, Optimapharm". New York, NY. 2020-05-12
Optibrium Ltd.. (5/12/20). "Press Release: Optibrium Adopts Cheminformatics Toolkits From OpenEye Scientific". Cambridge & Santa Fe, NM. 2020-05-12
Innovative Medicines Initiative (IMI). (5/12/20). "Press Release: IMI Announces COVID Projects, Boosts Funding Pot to EUR 72 million". Brussels. 2020-05-12
Freeline Therapeutics Ltd.. (5/4/20). "Press Release: Freeline Receives Orphan Drug Designation from the FDA for FLT190 for the Treatment of Fabry Disease". London. 2020-05-04
[iito] Business Intelligence. (5/4/20). "Press Release: [iito] Brings Back the Past into the [LSE] Newsletter". Bremen. 2020-05-04
Hyloris Pharmaceuticals S.A.. (4/30/20). "Press Release: Hyloris Pharmaceuticals Successfully Raises €15 Million in Funding Round". Liège. 2020-04-30
Syncona Ltd.. (4/30/20). "Press Release: Danny Bar-Zohar Joins Syncona as Partner". 2020-04-30
1 2 3 ... 42 43 44  next pagenext page



Advertisement

Picture [iito] No Tracking 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

» top